A detailed history of Syntax Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Syntax Advisors, LLC holds 12,005 shares of OGN stock, worth $179,474. This represents 0.36% of its overall portfolio holdings.

Number of Shares
12,005
Previous 11,616 3.35%
Holding current value
$179,474
Previous $241,000 13.69%
% of portfolio
0.36%
Previous 0.37%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $6,453 - $9,246
389 Added 3.35%
12,005 $208,000
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $20,291 - $25,935
1,053 Added 9.97%
11,616 $241,000
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $34,421 - $51,552
1,607 Added 17.94%
10,563 $248,000
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $7,948 - $9,756
341 Added 3.96%
8,956 $250,000
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $42,822 - $62,677
1,830 Added 26.97%
8,615 $202,000
Q2 2022

Aug 12, 2022

BUY
$31.66 - $38.9 $11,935 - $14,665
377 Added 5.88%
6,785 $229,000
Q1 2022

May 11, 2022

SELL
$30.45 - $39.36 $80,814 - $104,461
-2,654 Reduced 29.29%
6,408 $224,000
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $259,807 - $336,472
9,062 New
9,062 $276,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.8B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Syntax Advisors, LLC Portfolio

Follow Syntax Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syntax Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syntax Advisors, LLC with notifications on news.